Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Current Leases: 2018-2024

Historic Current Leases for KalVista Pharmaceuticals (KALV) over the last 4 years, with Apr 2024 value amounting to $1.3 million.

  • KalVista Pharmaceuticals' Current Leases was N/A to $1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2024, which is N/A change from last year.
  • As of FY2024, KalVista Pharmaceuticals' Current Leases stood at $1.3 million, which was up 121.43% from $588,000 recorded in FY2020.
  • KalVista Pharmaceuticals' Current Leases' 5-year high stood at $1.3 million during FY2024, with a 5-year trough of $588,000 in FY2020.
  • Over the past 1 years, KalVista Pharmaceuticals' median Current Leases value was $1.3 million (recorded in 2024), while the average stood at $1.3 million.
  • Data for KalVista Pharmaceuticals' Current Leases shows a peak YoY skyrocketed of 988.89% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows KalVista Pharmaceuticals' Current Leases stood at $588,000 in 2020, then followed by $1.3 million in 2024.